HomeReleasesAssort Health Hits $1.2 Billion Valuation to Scale...
Releases

Assort Health Hits $1.2 Billion Valuation to Scale AI Patient Agents

Assort Health Hits $1.2 Billion Valuation to Scale AI Patient Agents

San Francisco-based Assort Health has secured $120 million in Series C funding led by Menlo Ventures, pushing the company’s valuation to $1.2 billion. The startup, which utilizes proprietary AI to automate administrative workflows like scheduling and referrals, has now raised over $222 million to expand its healthcare operations platform.

Healthcare providers currently navigate a $1.1 trillion annual administrative burden, a figure nearly doubling their expenditure on direct patient care. Assort Health aims to bridge this gap by deploying voice-enabled AI agents that handle complex tasks ranging from document processing to real-time insurance eligibility. Driven by its proprietary Synapse model, the platform has processed over 190 million patient interactions, allowing it to refine decision pathways across 62,000 unique care protocols.

Scaling Specialty Care

The company’s rapid growth—revenue has increased 20-fold over the last 15 months—reflects a broader industry shift toward unified platforms over fragmented point solutions. By integrating tools like Concierge, Activate, Orchestrate, and Empower, Assort maintains a continuous "Patient Journey Memory." This data-driven approach enables providers such as the Boston Bone and Joint Institute and MDCS Dermatology to automate complex specialty workflows while reducing staff burnout. With the new capital, founders Jon Wang and Jeffery Liu plan to accelerate their expansion into larger health systems, including academic medical centers, as they look to consolidate the market for automated patient access.

Share:TelegramXFacebook

Read Also

Comments (0)

Leave a comment

No comments yet. Be the first!